Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Research interviews
-
1. The regulation of cell therapy
- Prof. Moutih Rafei
-
2. How and why neurons die in Alzheimer's disease?
- Prof. Bart De Strooper
-
3. The future of blood tests in cancer treatment
- Dr. Isaac Garcia-Murillas
-
4. Role of marketing authorization holder in drug safety
- Dr. Raphael Elmadjian Pareschi
-
5. Synthetic whole embryo models and their applications
- Prof. Jacob (Yaqub) Hanna
-
6. Scale-up challenges in the production of nanomedicines from lab to industry
- Prof. Dr. Oya Tagit
-
7. Artificial intelligence in precision medicine
- Dr. Michael P. Menden
-
8. Translational medicine: the risk of failure in delay and how to reduce it
- Prof. Martin Wehling
-
9. Challenges and solutions of scaling up
- Dr. Shaukat Ali
-
11. Management of generic drug development: challenges and opportunities
- Mr. Sandeep Patil
-
12. MassBank development and future
- Dr. Emma L. Schymanski
-
13. Elite controllers of HIV: from discovery to future therapies
- Prof. Bruce Walker
-
14. Translational research in amyotrophic lateral sclerosis (ALS)
- Prof. Aaron D. Gitler
-
16. PANDAS: a potential link between group A streptococcal infections and neurological disorders
- Prof. P. Patrick Cleary
-
17. Rheumatic diseases and musculoskeletal pain
- Prof. Anisur Rahman
-
18. Towards developing a universal influenza vaccine
- Prof. Peter Palese
- Clinical interviews
-
19. Monkeypox: etiopathogenesis, prevention, and treatments
- Dr. Dennis Hruby
-
20. Kidney xenotransplantation
- Dr. Douglas J. Anderson
-
21. CAR-T and TCR-T cellular immunotherapies in oncology
- Prof. Sebastian Kobold
-
22. MAPS: the business of medical affairs
- Dr. Danie du Plessis
-
23. Hypertrophic cardiomyopathy: therapies and treatments
- Prof. Srihari Naidu
-
24. Combating the HIV epidemic
- Prof. William Blattner
-
25. Epigenetic pharmaceuticals used in the clinic
- Dr. Thomas Paul
-
26. Precision cancer medicine: development and future
- Prof. Maurie Markman
-
27. Pediatric cancer testing
- Prof. Joshua Schiffman
-
28. Opposition to vaccination: a transatlantic discussion
- Prof. Jonathan Temte
-
29. Elective caesarean sections from an evolutionary perspective
- Prof. Wenda Trevathan
-
30. Antiphospholipid syndrome and Lupus
- Prof. Graham Hughes
-
31. Prescribing medications to children - a GP’s view
- Dr. Amanda Simmons
Topics Covered
- Anti-vaccination movements in the US and the EU
- The impact of vaccine opposition on the numbers of measles and influenza cases
- The influence of public and social media on pro/anti-vaccines debate
- Lack of public’s trust in the pharmaceutical industry and regulatory agencies in the US and the EU
- The demographics of anti-vaccinators in the US and the UK
- Challenges in communicating the safety and importance of vaccine to the public
Biography
Dr. Temte is professor of family medicine at the University of Wisconsin School of Medicine and Public Health and chair of the U.S. Advisory Committee on Immunization Practices (ACIP). He has chaired ACIP work groups on MMRV Safety, Evidence-based Recommendations, and MMR Vaccine. He received his BA in biology from Luther College, MS in biological oceanography from Oregon State University, PhD in zoology and MD from the University of Wisconsin. His current area of interest is influenza surveillance in primary care and vaccine policy.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Temte, J. (2018, May 30). Opposition to vaccination: a transatlantic discussion [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/UVAD8102.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Jonathan Temte has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Microbiology
Transcript
Please wait while the transcript is being prepared...
0:00
Interviewer: Hello Jonathan. I'm Terry Matthews.
I'm a retired pediatrician and it's going to be a pleasure to talk to you today,
on what I believe is the very important topic of immunization,
particularly of our children.
One aspect that's interested me and I think is particularly relevant at the moment,
is the reasons that parents refuse to have their children vaccinated,
a group which I think you call anti-vaccines.
We do have a particular problem in Europe at the moment
as particularly measles cases have risen by 300% in Europe over the last year,
as parents right across the continent have shunned all vaccines,
and we have got a bit of an outbreak at the moment with more than
20,000 people affected over the course from a record low in the recent past,
and involving 35 deaths.
Large number of countries involved but particularly Romania and Italy,
and immunization policies do seem to be fading.
I wonder John, what you thought were the most important reasons why this was the case?
Prof. Temte: Well, it turns out that I started my morning checking the news on the Internet.
One of the first stories that popped up was
the high number of cases across Europe of measles.
The situation across Europe right now with the large number of cases of
measles is emblematic of a central theme.
Parents are concerned about safety for their children.
We currently live at a time when